Free Trial

Acumen Pharmaceuticals (ABOS) News Today

Acumen Pharmaceuticals logo
$1.42 +0.02 (+1.43%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$1.42 +0.01 (+0.35%)
As of 08/15/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABOS Latest News

Cantor Fitzgerald Issues Negative Forecast for ABOS Earnings
Cantor Fitzgerald Issues Negative Outlook for ABOS Earnings
Earnings Scheduled For August 12, 2025
Brokers Issue Forecasts for ABOS FY2026 Earnings
Q4 2024 Acumen Pharmaceuticals Inc Earnings Call
Acumen price target lowered to $11 from $15 at H.C. Wainwright
Acumen completes enrollment of ALTITUDE-AD Phase 2 trial
Get Acumen Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABOS and its competitors with MarketBeat's FREE daily newsletter.

ABOS Media Mentions By Week

ABOS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABOS
News Sentiment

-0.18

0.64

Average
Medical
News Sentiment

ABOS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABOS Articles
This Week

14

2

ABOS Articles
Average Week

Get Acumen Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABOS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ABOS) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners